[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4385 followers
Created: 2025-07-23 12:30:06 UTC

$IRD Joint Ventures:

Opus Genetics, Inc. announced on July 22, 2025, a funding and license agreement allowing for up to $XXX million to develop gene therapies for inherited retinal degeneration associated with the RDH12 gene.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947997650739183772/c:line.svg)

**Related Topics**
[joint ventures](/topic/joint-ventures)
[$ird](/topic/$ird)

[Post Link](https://x.com/USCorpFilings/status/1947997650739183772)